 |
eKnowledge - Diabetes: Lectures for Clinical P... |
|---|
| このアプリは現在ストアで閲覧することができません。 | ||||
|
価格 | 無料 | ダウンロード |
|
|---|---|---|---|---|
| ｼﾞｬﾝﾙ | メディカル | |||
サイズ | 43.4MB | |||
| 開発者 | Projects In Knowledge, Inc. | |||
| 順位 |
| |||
| ﾘﾘｰｽ日 | 2011-03-13 15:22:20 | 評価 | 評価が取得できませんでした。 | |
| 互換性 | iOS 3.1.3以降が必要です。 iPhone、iPad および iPod touch 対応。 | |||
|
||||
These engaging presentations offer practical instruction on type 2 diabetes mellitus pathophysiology, early diagnosis, goals of therapy and care, novel treatments, management of hypertension and dyslipidemia, patient monitoring, and treatment guidelines. In addition, these activities will touch on recent controversies relating to measurement and application of HbA1c levels, inconsistencies between current T2DM guidelines, and intensive versus standard therapy.
Learn about the relationship between HbA1c and glycemia, the risks and benefits of treatment in general and intensive glycemic control in particular, the physiologic defects that lead to chronic hyperglycemia in T2DM, and whether or not diabetic patients remain vulnerable to microvascular and macrovascular complications even when blood sugar is well controlled.
New and emerging therapies are also covered, including SGLT-2 inhibitors (how they work, what they can achieve, their safety profile, and their potential role in the management of T2DM) and incretin-based therapies, including GLP-1 agonists/analogs and DPP-4 inhibitors (their mechanisms of action, and safety and efficacy data).
A case study is presented to illustrate how to individualize HbA1c targets, selection of initial treatment, and considerations for choosing among the numerous options now available or emerging for add-on therapy in patients who have not met treatment goals with monotherapy.
Each presentation offers free CME, CE, and CPE credit to diabetologists, endocrinologists, internists, primary care physicians, nurse practitioners, nurses, and pharmacists who participate in the care of patients with type 2 diabetes.
更新履歴
Performance and stability improvements.
Learn about the relationship between HbA1c and glycemia, the risks and benefits of treatment in general and intensive glycemic control in particular, the physiologic defects that lead to chronic hyperglycemia in T2DM, and whether or not diabetic patients remain vulnerable to microvascular and macrovascular complications even when blood sugar is well controlled.
New and emerging therapies are also covered, including SGLT-2 inhibitors (how they work, what they can achieve, their safety profile, and their potential role in the management of T2DM) and incretin-based therapies, including GLP-1 agonists/analogs and DPP-4 inhibitors (their mechanisms of action, and safety and efficacy data).
A case study is presented to illustrate how to individualize HbA1c targets, selection of initial treatment, and considerations for choosing among the numerous options now available or emerging for add-on therapy in patients who have not met treatment goals with monotherapy.
Each presentation offers free CME, CE, and CPE credit to diabetologists, endocrinologists, internists, primary care physicians, nurse practitioners, nurses, and pharmacists who participate in the care of patients with type 2 diabetes.
更新履歴
Performance and stability improvements.
ブログパーツ第二弾を公開しました！ホームページでアプリの順位・価格・周辺ランキングをご紹介頂けます。
ブログパーツ第2弾！
アプリの周辺ランキングを表示するブログパーツです。価格・順位共に自動で最新情報に更新されるのでアプリの状態チェックにも最適です。
ランキング圏外の場合でも周辺ランキングの代わりに説明文を表示にするので安心です。
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。ただし、一般公開されているページでご使用頂かないと表示されませんのでご注意ください。
幅200px版
幅320px版
お気に入りのアプリをご紹介頂くためのブログパーツです。アプリの価格や順位表示は毎日自動更新♪
サンプルが気に入りましたら、下に表示されたHTMLタグをそのままページに貼り付けることでご利用頂けます。
※配信を停止させていただく可能性もございますので、タグの改変はご遠慮ください。
Now Loading...
「iPhone & iPad アプリランキング」は、最新かつ詳細なアプリ情報をご紹介しているサイトです。
お探しのアプリに出会えるように様々な切り口でページをご用意しております。
「メニュー」よりぜひアプリ探しにお役立て下さい。
Presents by $$308413110 スマホからのアクセスにはQRコードをご活用ください。 →
Now loading...